HCP Inc

HCP-N

NYSE:HCP

35.78
0.00 (0.00%)
HCP, Inc., formerly Healthcare Property Investors Inc., is a Real Estate Investment Trust, invests primarily in real estate serving the United States healthcare industry.
More at Wikipedia

Analysis and Opinions about HCP-N

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
January 29, 2019
(A Top Pick Mar 13/18, Up 40%) One of his top performers. Pays a good dividend. Exit at $29. Loves it.
Show full opinionHide full opinion
HCP Inc (HCP-N)
January 29, 2019
(A Top Pick Mar 13/18, Up 40%) One of his top performers. Pays a good dividend. Exit at $29. Loves it.
PAST TOP PICK
PAST TOP PICK
August 8, 2018

(A Top Pick March 13/18 Up 17%) It found a nice bottom near $22 and pays a good dividend. He will keep a stop of $24.25. It could hit $30 by year end.

Show full opinionHide full opinion
HCP Inc (HCP-N)
August 8, 2018

(A Top Pick March 13/18 Up 17%) It found a nice bottom near $22 and pays a good dividend. He will keep a stop of $24.25. It could hit $30 by year end.

PAST TOP PICK
PAST TOP PICK
April 10, 2018

(A Past Top Pick on March 13, 2018, Up 0.08%) Expects a return in the next three months. This could $100 in 10 years. Maybe. It's still going up. It's on his buy list. It's gone up a bit relative to the market.

Show full opinionHide full opinion
HCP Inc (HCP-N)
April 10, 2018

(A Past Top Pick on March 13, 2018, Up 0.08%) Expects a return in the next three months. This could $100 in 10 years. Maybe. It's still going up. It's on his buy list. It's gone up a bit relative to the market.

TOP PICK
TOP PICK
March 13, 2018

This is a diversified health-care REIT, trading at multi-year lows, looks like it’s bouncing off them. Good yield. Value and income look right here. He is planning a buying program for this. He would use a stop at $21.50 because of the support there. (Analysts’ price target is 26.29$)

Show full opinionHide full opinion
HCP Inc (HCP-N)
March 13, 2018

This is a diversified health-care REIT, trading at multi-year lows, looks like it’s bouncing off them. Good yield. Value and income look right here. He is planning a buying program for this. He would use a stop at $21.50 because of the support there. (Analysts’ price target is 26.29$)

Showing 1 to 4 of 4 entries
  • «
  • 1
  • »